Repository landing page
The expression levels of CD80 (A), CD86 (B) and HLA-DR (C) on various regimens treated iDCs.
Abstract
<p>The iDCs were treated with mock, BCG-CS-NPs, UVI-DENV (1, 3 and 10 μg) and DNV (1, 3 and 10 μg) for 24, 48 and 72 h. The expressions of CD80, CD86 and HLA-DR were determined as the mean fluorescence intensity (MFI) by flow cytometry. <sup>a</sup> indicates significant difference between mock- and adjuvant-treated culture. *,** and *** indicate significant difference in MFI level of CD80, CD86 and HLA-DR between DNV and UVI-DENV antigen at 1 μg, 3 μg and 10 μg, respectively.</p- Image
- Figure
- Uncategorised
- loading efficacies
- thp
- emulsion polymerization method
- DENV infection
- idc
- component
- cationic surface properties
- bcg
- delivery system
- chitosan nanoparticles
- DENV infections
- dengue vaccines
- scanning electron microscope
- chemokine productions
- Human Dendritic Cells Dengue viruses
- novel dengue nanovaccine
- immunogenic properties
- DNV stimulation
- DCs maturation markers
- Dendritic cells
Similar works
Full text
Last time updated on 12/02/2018
This paper was published in The Francis Crick Institute.
Having an issue?
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.